Niva Bupa Health Insurance Stock Price: On Monday, June 2, about 56.3 lakh shares of Niva Bupa Health Insurance were purchased in a block deal. The value of this sale is said to be Rs 391 crore. Due to this, the share price on BSE fell by 11 percent to Rs 82 from the previous closed price in early trade. The company’s market cap is Rs 15200 crore. There is no official information about who has sold shares. But a day earlier a report by CNBC-TV18 quoted sources as saying that Fettle Tone and Krishnan Ramchandra could sell up to 7.2 percent stake in the company.
In such a situation, the speculation is that the sellers are both under the block deal. The block size for transactions was estimated to be around Rs 1,082 crore. According to the term sheet, the indoctive offer price for transactions was Rs 82. ICICI Securities and Kotak Mahindra Capital are investment banks working on this transaction.
Niva Bupa Health List was done in November 2024
Shares of Niva Bupa Health Insurance were listed on BSE, NSE on 14 November 2024. Its public issue was 1.9 times full. The stock has so far seen a record high of Rs 109.41 and a record of Rs 61.01 on BSE. The stock has jumped 14 percent in 3 months. British company Bupa holds 55.98 percent stake in the company and True North holds 17.47 percent stake through Fettle Tone LLP.
In April, brokerage firm Motilal Oswal launched coverage with ‘bye’ ratings for shares of Niva Bupa Health Insurance. Brokerage gave a target price of Rs 100 per share for the stock. 4 of the 5 analysts who covers the stock have rated “by” and one has given a “hold” rating.
Aegis Vopack Terminals IPO investors disappointment, share starts at 6% discount
The company saw an increase of 31.2% in net profit in the January-March 2025 quarter and it increased to ₹ 206 crore. The profit was ₹ 157 crore a year ago. The gross premium rose 18% to ₹ 2,078.7 crore, which was ₹ 1,759.4 crore in the same quarter of the previous year.
Disclaimer: Advice or idea experts/brokerage firms given on Moneycontrol.com have their own personal views. The website or management is not responsible for this. Moneycontrol advises to users that always seek the advice of certified experts before taking any investment decision.
